Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167932 · ClinicalTrials.gov registry record
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 127
- Enrollment target
NCT02167932 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 127 participants.
The verdict
NCT02167932 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
This study will look at whether or not participating in a physical activity intervention during chemotherapy for breast cancer can prevent a marker of aging called p16 from having a large increase after chemotherapy.
Interventions
- BEHAVIORAL Walk With Ease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02167932
The ClinicalTrials.gov registry entry for NCT02167932 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Walk With Ease is the first listed.
NCT02167932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02167932 about?
NCT02167932 is a clinical study titled "The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer". This study will look at whether or not participating in a physical activity intervention during chemotherapy for breast cancer can prevent a marker of aging called p16 from having a large increase after chemotherapy.
What is the current status of trial NCT02167932?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2014-03. Estimated completion is 2016-11-30.
What interventions are being tested in trial NCT02167932?
The interventions under investigation include: Walk With Ease (BEHAVIORAL).
Who is sponsoring clinical trial NCT02167932?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.